http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021187548-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b65747ed78f05dd9ebe107b50ce2855
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2021-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bf5486684244be89dd363bf0e5509c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2667670a22dc5d42131d14b988d1459c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_925c58bfcdc7b07731fe501c07049159
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf5e76aae43dbc0d0792c6321731fa67
publicationDate 2021-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021187548-A1
titleOfInvention Treatment or prevention method for chronic heart failure
abstract One purpose of the present invention is to treat or prevent chronic heart failure. Provided are: a pharmaceutical composition for treating or preventing chronic heart failure, said composition comprising a compound that inhibits SGLT1 or a pharmaceutically acceptable salt thereof; and a treatment or prevention method for chronic heart failure, said method being characterized by comprising administering a compound that inhibits SGLT1 or a pharmaceutically acceptable salt thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4026562-A4
priorityDate 2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019194207-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019151627-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019182852-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019168096-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013031922-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418722755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468285373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468307544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139570167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468296390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411012565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146256844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468306923

Total number of triples: 47.